Astellas Pharma Inc. (FRA:YPH)
Germany
· Delayed Price · Currency is EUR 10.76
+0.05 (0.51%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Pharmaceutical | 1,912.32B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 19.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| United States | 866.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 30.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Markets | 485.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Established Markets Growth | 16.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 267.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -1.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 203.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 27.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 78.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -11.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 11.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 60.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|